The report concerns the Ministry of Health and Prevention’s (Ministry of Health) programme for counselling on experimental treatment, generally referred to as the second-opinion programme.
The programme is administered by the Health and Medicines Authority, which has set up a panel of experts. Patients are referred to the panel by their treating doctor for an assessment of whether further treatment options, including experimental treatment, are available in Denmark or abroad that might benefit the patient.
The purpose of the examination is to assess whether the Ministry of Health has ensured that the second-opinion programme meets its objective of securing all patients with a life-threatening disease access to a final assessment of possible further treatment options.
Rigsrevisionen initiated the study in May 2014.
Read the 1st chapter of the report (PDF)